Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study

Abstract Background Platelet-rich plasma (PRP) is widely used in the management of lateral elbow tendinopathy (LET) despite conflicting evidence on its effectiveness. With high levels of user experience, this study aimed to assess consensus amongst experts on its clinical use. Methods A three-round...

Full description

Bibliographic Details
Main Authors: Jonathan P. Evans, Nicola Maffulli, Chris Smith, Adam Watts, Jose Valderas, Vicki Goodwin
Format: Article
Language:English
Published: SpringerOpen 2021-11-01
Series:Journal of Orthopaedics and Traumatology
Subjects:
Online Access:https://doi.org/10.1186/s10195-021-00608-5
_version_ 1819280904733851648
author Jonathan P. Evans
Nicola Maffulli
Chris Smith
Adam Watts
Jose Valderas
Vicki Goodwin
author_facet Jonathan P. Evans
Nicola Maffulli
Chris Smith
Adam Watts
Jose Valderas
Vicki Goodwin
author_sort Jonathan P. Evans
collection DOAJ
description Abstract Background Platelet-rich plasma (PRP) is widely used in the management of lateral elbow tendinopathy (LET) despite conflicting evidence on its effectiveness. With high levels of user experience, this study aimed to assess consensus amongst experts on its clinical use. Methods A three-round international Delphi study was conducted. Participants were invited through national society mailing lists and contact lists derived from a systematic search of the literature on PRP. In round one, a primary working group developed 40 statements on PRP preparation and clinical application. In rounds two and three, an international group of researchers on PRP and clinical users of the device scored their levels of agreement with the statements on a five-point scale. Consensus was defined as an interquartile range of ≤ 1. Results Consensus of agreement was only reached for 17/40 (42.5%) statements. For statements on PRP formulation, consensus of agreement was reached in 2/6 statements (33%). Only limited consensus on the contraindications, delivery strategy and delivery technique was achieved. Conclusion Experts reached very limited consensus on the use of PRP in LET. High levels of user experience have not resulted in a convergence of opinion on the technical components of PRP formulation and delivery, substantiating the need for further studies and improved trial reporting.
first_indexed 2024-12-24T00:51:13Z
format Article
id doaj.art-7e08819dfaa44394908f539e01ecf166
institution Directory Open Access Journal
issn 1590-9921
1590-9999
language English
last_indexed 2024-12-24T00:51:13Z
publishDate 2021-11-01
publisher SpringerOpen
record_format Article
series Journal of Orthopaedics and Traumatology
spelling doaj.art-7e08819dfaa44394908f539e01ecf1662022-12-21T17:23:34ZengSpringerOpenJournal of Orthopaedics and Traumatology1590-99211590-99992021-11-0122111010.1186/s10195-021-00608-5Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi studyJonathan P. Evans0Nicola Maffulli1Chris Smith2Adam Watts3Jose Valderas4Vicki Goodwin5Royal Devon and Exeter NHS Foundation TrustDepartment of Musculoskeletal Disorders, University of SalernoRoyal Devon and Exeter NHS Foundation TrustWrightington Wigan and Leigh NHS Trust, Wrightington HospitalHealth Services and Policy Research Group, University of ExeterNational Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) South West Peninsula, University of Exeter Medical SchoolAbstract Background Platelet-rich plasma (PRP) is widely used in the management of lateral elbow tendinopathy (LET) despite conflicting evidence on its effectiveness. With high levels of user experience, this study aimed to assess consensus amongst experts on its clinical use. Methods A three-round international Delphi study was conducted. Participants were invited through national society mailing lists and contact lists derived from a systematic search of the literature on PRP. In round one, a primary working group developed 40 statements on PRP preparation and clinical application. In rounds two and three, an international group of researchers on PRP and clinical users of the device scored their levels of agreement with the statements on a five-point scale. Consensus was defined as an interquartile range of ≤ 1. Results Consensus of agreement was only reached for 17/40 (42.5%) statements. For statements on PRP formulation, consensus of agreement was reached in 2/6 statements (33%). Only limited consensus on the contraindications, delivery strategy and delivery technique was achieved. Conclusion Experts reached very limited consensus on the use of PRP in LET. High levels of user experience have not resulted in a convergence of opinion on the technical components of PRP formulation and delivery, substantiating the need for further studies and improved trial reporting.https://doi.org/10.1186/s10195-021-00608-5Platelet-rich plasmaPRPConsensusElbowTendinopathyTennis elbow
spellingShingle Jonathan P. Evans
Nicola Maffulli
Chris Smith
Adam Watts
Jose Valderas
Vicki Goodwin
Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
Journal of Orthopaedics and Traumatology
Platelet-rich plasma
PRP
Consensus
Elbow
Tendinopathy
Tennis elbow
title Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
title_full Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
title_fullStr Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
title_full_unstemmed Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
title_short Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
title_sort even experts cannot agree on the optimal use of platelet rich plasma in lateral elbow tendinopathy an international delphi study
topic Platelet-rich plasma
PRP
Consensus
Elbow
Tendinopathy
Tennis elbow
url https://doi.org/10.1186/s10195-021-00608-5
work_keys_str_mv AT jonathanpevans evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy
AT nicolamaffulli evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy
AT chrissmith evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy
AT adamwatts evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy
AT josevalderas evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy
AT vickigoodwin evenexpertscannotagreeontheoptimaluseofplateletrichplasmainlateralelbowtendinopathyaninternationaldelphistudy